24 results on '"Treat L"'
Search Results
2. Creation of secondary AV fistulas from failed hemodialysis grafts: the role of routine vein mapping
- Author
-
NGUYEN, V. D., TREAT, L., GRIFFITH, C., and ROBINSON, K.
- Published
- 2007
Catalog
3. Successful multidisciplinary interventions for arterio-venous fistula creation by the Pacific Northwest Renal Network 16 vascular access quality improvement program
- Author
-
NGUYEN, V. D., LAWSON, L., LEDEEN, M., TREAT, L., BUSS, J., BARCLAY, C., ALFORD, S., REUS, J., and GRIFFITH, C.
- Published
- 2007
4. Sicherheit und Wirksamkeit von Propafenon bei der Unterdrückung ventrikulärer Ektopien
- Author
-
deSoyza, N., Murphy, M., Sakhaii, M., Treat, L., Schlepper, M., editor, and Olsson, B., editor
- Published
- 1983
- Full Text
- View/download PDF
5. The Safety and Efficacy of Propafenone in Suppressing Ventricular Ectopy
- Author
-
deSoyza, N., Murphy, M., Sakhaii, M., Treat, L., Schlepper, M., editor, and Olsson, B., editor
- Published
- 1983
- Full Text
- View/download PDF
6. Fistula first: vascular access update. A multi-center perspective of the buttonhole technique in the Pacific Northwest.
- Author
-
Ball LK, Treat L, Riffle V, Scherting D, Swift L, and Ball L
- Abstract
There is no solid data on how many dialysis facilities and home hemodialysis programs in the United States are cannulating arteriovenous fistulas via the Buttonhole Technique. In the Pacific Northwest (Northwest Renal Network #16), approximately 38% of facilities are utilizing the buttonhole technique. In this article, four of those facilities will share their experiences, which suggest the Buttonhole Technique is a viable AVF cannulation option that has fewer complications than site rotation and a higher level of patient satisfaction. [ABSTRACT FROM AUTHOR] more...
- Published
- 2007
7. Targeted drug delivery in the brain via ultrasound-induced blood-brain barrier disruption.
- Author
-
McDannold, N., Treat, L., Vykhodtseva, N., and Hynynen, K.
- Published
- 2009
- Full Text
- View/download PDF
8. Murder most puzzling: Can you solve this case?
- Author
-
Treat, L.
- Subjects
- *
MYSTERY fiction - Abstract
Poses a murder mystery for readers to solve. Includes answers.
- Published
- 1989
9. Pediatric Neuropalliative Medicine.
- Author
-
Shear T, Bogetz JF, and Treat L
- Subjects
- Humans, Child, Neurology, Neurological Rehabilitation methods, Nervous System Diseases therapy, Pediatrics
- Abstract
Neurological disease in childhood has significant impacts on not only physical well-being, but also on the social, environmental, and emotional health of the child, their family, and the larger community. Pediatric neuropalliative medicine is a recently developed area of subspecialty practice that supports families affected by serious neurological illness in navigating uncertain illness trajectories, refractory symptoms, and the myriad medical decisions that arise over the life of the child. Despite their medical needs, children with neurological diseases live full, joyful, and connected lives with their families, many of whom also experience personal growth and find meaning in their caregiving. Patients and families under the care of neurologists also face many systemic and interpersonal biases, both within the health care system and in the community, and encounter frequent gaps in their home and community-based supports. This chapter summarizes what is known about pediatric neuropalliative medicine and highlights the future research, educational, and clinical innovations that are needed to build more comprehensive and well-prepared systems to address unmet needs. Particularly in the modern era of child neurology practice where disease-modifying treatments are becoming increasingly available, pediatric neuropalliative medicine is an essential area of subspecialty practice that helps to support the personhood and quality of life of the individuals affected by serious illness and their families. As medicine helps more and more children with neurological impairment survive, medical treatment must include not only treatment for the physical body, but also care and support for the complexity of human experience of living with serious illness., Competing Interests: None declared., (Thieme. All rights reserved.) more...
- Published
- 2024
- Full Text
- View/download PDF
10. Promoting a neuropalliative care approach in fetal neurology.
- Author
-
Nanduri N, Bansal S, Treat L, Bogetz JF, Wusthoff CJ, Rent S, and Lemmon ME
- Subjects
- Humans, Pregnancy, Female, Neurology methods, Nervous System Diseases therapy, Fetal Diseases therapy
- Abstract
Competing Interests: Declaration of competing interest Dr. Bogetz has received grants for unrelated work from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Palliative Care Research Center, Cambia Health Foundation, Seattle Children’s Research Institute, and Lucile Packard Foundation for Children’s Health. Dr. Rent receives funding from the National Palliative Care Research Center. Dr. Wusthoff has served on a data safety monitoring board for PRA Health Sciences, ICON, and University of Utah; serves as an associate editor for Neurology and Journal of Clinical Neurophysiology; and receives funding from NIH, Thrasher Research Fund, and Medicure. Dr. Lemmon receives funding from the National Institute of Health and the BAND foundation. more...
- Published
- 2024
- Full Text
- View/download PDF
11. ATS Core Curriculum 2022. Pediatric Pulmonary Medicine: Updates in pediatric neuromuscular disease.
- Author
-
Leon-Astudillo C, Okorie CUA, McCown MY, Dy FJ, Puranik S, Prero M, ElMallah MK, Treat L, and Gross JE
- Subjects
- Humans, Child, Respiration, Curriculum, Pulmonary Medicine, Neuromuscular Diseases diagnosis, Neuromuscular Diseases therapy, Respiratory Insufficiency etiology, Respiratory Insufficiency therapy, Muscular Atrophy, Spinal
- Abstract
The American Thoracic Society Core Curriculum updates clinicians annually in pediatric pulmonary disease. This is a concise review of the Pediatric Pulmonary Medicine Core Curriculum presented at the 2022 American Thoracic Society International Conference. Neuromuscular diseases (NMD) comprise a variety of conditions that commonly affect the respiratory system and cause significant morbidity including dysphagia, chronic respiratory failure, and sleep disordered breathing. Respiratory failure is the most common cause of mortality in this population. Substantial progress has been made in diagnosis, monitoring and treatment for NMD over the last decade. Pulmonary function testing (PFT) is utilized to objectively measure respiratory pump function and PFT milestones are utilized in NMD-specific pulmonary care guidelines. New disease modifying therapies are approved for the treatment of patients with Duchenne muscular dystrophy and spinal muscular atrophy (SMA), including the first ever approved systemic gene therapy, in the case of SMA. Despite extraordinary progress in the medical management of NMD, little is known regarding the respiratory implications and long-term outcomes for patients in the era of advanced therapeutics and precision medicine. The combination of technological and biomedical advancements has increased the complexity of the medical decision-making process for patients and families, thus emphasizing the importance of balancing respect for autonomy with the other foundational principles of medical ethics. This review features an overview of PFT, noninvasive ventilation strategies, novel and developing therapies, as well as the ethical considerations specific to the management of patients with pediatric NMD., (© 2023 Wiley Periodicals LLC.) more...
- Published
- 2023
- Full Text
- View/download PDF
12. Congruent Communication: Addressing Culture and Care for a Seriously Ill Rohingya Infant.
- Author
-
Treat L and Macauley R
- Subjects
- Child, Humans, Infant, Communication, Patient-Centered Care, Palliative Care, Quality of Life
- Abstract
Pediatric palliative care teams seek to collaboratively promote the quality of life for children with serious medical illness in the context of the values expressed by the patient and family. Especially for infants with high medical fragility, shared decision making can be a complex task that often requires flexibility to respond to the clinical circumstances at hand, as well as contextualization within the family culture. In this paper, we present the case of an infant with a severe congenital brain malformation who was born in an American hospital to a Rohingya-speaking, Burmese family whose care preferences seemed to oscillate between comfort-focused and life-prolonging without clear acknowledgement of the consequences of shifting between treatment plans. Discussion of this case helps to illustrate the cultural factors, ethical challenges, and systems-level issues that can arise for medical teams in seeking to promote patient-centered care that respects family values while also honoring the principle of nonmaleficience., (Copyright © 2022 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.) more...
- Published
- 2023
- Full Text
- View/download PDF
13. What Do Parents of Seriously Ill Infants With Neurologic Conditions Want From Their Medical Team? Starting Out With Care.
- Author
-
Treat L and Dingman A
- Subjects
- Infant, Humans, Decision Making, Parents, Nervous System Diseases therapy
- Published
- 2023
- Full Text
- View/download PDF
14. Pediatric neuropalliative care.
- Author
-
HarnEnz Z, Vermilion P, Foster-Barber A, and Treat L
- Subjects
- Adult, Child, Humans, Quality of Life, Palliative Care, Communication, Nervous System Diseases, Neurology
- Abstract
Pediatric palliative care seeks to support quality of life for children and families affected by serious illness. Children with neurological disease are among the most frequent recipients of pediatric palliative care. Several important elements distinguish pediatric palliative care from adult practice, including a longer illness duration, longitudinal relationships over the span of years, diseases characterized by chronic fragility rather than progressive pathology, and the reliance on parents as proxy decision makers. This chapter will provide an overview of pediatric neuropalliative care, with emphasis on the types of disease trajectories, symptom management, and communication principles for supporting shared decision making with families. The role of neurology expertise is highlighted throughout, with special attention toward incorporating palliative care into pediatric neurology practice., (Copyright © 2023 Elsevier B.V. All rights reserved.) more...
- Published
- 2023
- Full Text
- View/download PDF
15. Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
- Author
-
McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS, Berg AT, Borlot F, Esplin ED, Moretz C, Angione K, Ríos-Pohl L, Nussbaum RL, Aradhya S, Haldeman-Englert CR, Levy RJ, Parachuri VG, Lay-Son G, de Montellano DJD, Ramirez-Garcia MA, Benítez Alonso EO, Ziobro J, Chirita-Emandi A, Felix TM, Kulasa-Luke D, Megarbane A, Karkare S, Chagnon SL, Humberson JB, Assaf MJ, Silva S, Zarroli K, Boyarchuk O, Nelson GR, Palmquist R, Hammond KC, Hwang ST, Boutlier SB, Nolan M, Batley KY, Chavda D, Reyes-Silva CA, Miroshnikov O, Zuccarelli B, Amlie-Wolf L, Wheless JW, Seinfeld S, Kanhangad M, Freeman JL, Monroy-Santoyo S, Rodriguez-Vazquez N, Ryan MM, Machie M, Guerra P, Hassan MJ, Candee MS, Bupp CP, Park KL, Muller E 2nd, Lupo P, Pedersen RC, Arain AM, Murphy A, Schatz K, Mu W, Kalika PM, Plaza L, Kellogg MA, Lora EG, Carson RP, Svystilnyk V, Venegas V, Luke RR, Jiang H, Stetsenko T, Dueñas-Roque MM, Trasmonte J, Burke RJ, Hurst ACE, Smith DM, Massingham LJ, Pisani L, Costin CE, Ostrander B, Filloux FM, Ananth AL, Mohamed IS, Nechai A, Dao JM, Fahey MC, Aliu E, Falchek S, Press CA, Treat L, Eschbach K, Starks A, Kammeyer R, Bear JJ, Jacobson M, Chernuha V, Meibos B, Wong K, Sweney MT, Espinoza AC, Van Orman CB, Weinstock A, Kumar A, Soler-Alfonso C, Nolan DA, Raza M, Rojas Carrion MD, Chari G, Marsh ED, Shiloh-Malawsky Y, Parikh S, Gonzalez-Giraldo E, Fulton S, Sogawa Y, Burns K, Malets M, Montiel Blanco JD, Habela CW, Wilson CA, Guzmán GG, and Pavliuk M more...
- Subjects
- Humans, Female, Infant, Newborn, Infant, Child, Preschool, Child, Adolescent, Young Adult, Adult, Middle Aged, Male, Retrospective Studies, Cross-Sectional Studies, Seizures genetics, Genetic Testing methods, Epilepsy drug therapy, Epilepsy genetics
- Abstract
Importance: It is currently unknown how often and in which ways a genetic diagnosis given to a patient with epilepsy is associated with clinical management and outcomes., Objective: To evaluate how genetic diagnoses in patients with epilepsy are associated with clinical management and outcomes., Design, Setting, and Participants: This was a retrospective cross-sectional study of patients referred for multigene panel testing between March 18, 2016, and August 3, 2020, with outcomes reported between May and November 2020. The study setting included a commercial genetic testing laboratory and multicenter clinical practices. Patients with epilepsy, regardless of sociodemographic features, who received a pathogenic/likely pathogenic (P/LP) variant were included in the study. Case report forms were completed by all health care professionals., Exposures: Genetic test results., Main Outcomes and Measures: Clinical management changes after a genetic diagnosis (ie, 1 P/LP variant in autosomal dominant and X-linked diseases; 2 P/LP variants in autosomal recessive diseases) and subsequent patient outcomes as reported by health care professionals on case report forms., Results: Among 418 patients, median (IQR) age at the time of testing was 4 (1-10) years, with an age range of 0 to 52 years, and 53.8% (n = 225) were female individuals. The mean (SD) time from a genetic test order to case report form completion was 595 (368) days (range, 27-1673 days). A genetic diagnosis was associated with changes in clinical management for 208 patients (49.8%) and usually (81.7% of the time) within 3 months of receiving the result. The most common clinical management changes were the addition of a new medication (78 [21.7%]), the initiation of medication (51 [14.2%]), the referral of a patient to a specialist (48 [13.4%]), vigilance for subclinical or extraneurological disease features (46 [12.8%]), and the cessation of a medication (42 [11.7%]). Among 167 patients with follow-up clinical information available (mean [SD] time, 584 [365] days), 125 (74.9%) reported positive outcomes, 108 (64.7%) reported reduction or elimination of seizures, 37 (22.2%) had decreases in the severity of other clinical signs, and 11 (6.6%) had reduced medication adverse effects. A few patients reported worsening of outcomes, including a decline in their condition (20 [12.0%]), increased seizure frequency (6 [3.6%]), and adverse medication effects (3 [1.8%]). No clinical management changes were reported for 178 patients (42.6%)., Conclusions and Relevance: Results of this cross-sectional study suggest that genetic testing of individuals with epilepsy may be materially associated with clinical decision-making and improved patient outcomes. more...
- Published
- 2022
- Full Text
- View/download PDF
16. The Lived Experience of Parents' Receiving the Diagnosis of CDKL5 Deficiency Disorder for Their Child.
- Author
-
Demarest S, Marsh R, Treat L, Fisher MP, Dempsey A, Junaid M, Downs J, Leonard H, Benke T, and Morris MA
- Subjects
- Adolescent, Child, Family, Humans, Parents, Protein Serine-Threonine Kinases genetics, Epileptic Syndromes diagnosis, Epileptic Syndromes genetics, Spasms, Infantile diagnosis, Spasms, Infantile genetics
- Abstract
CDKL5 deficiency disorder (CDD), a severe developmental and epileptic encephalopathy, is being diagnosed earlier with improved access to genetic testing, but this may also have unanticipated impacts on parents' experience receiving the diagnosis. This study explores the lived experience of parents receiving a diagnosis of CDD for their child using mixed methods. Thirty-seven semistructured interviews were conducted with parents of children with a diagnosis of CDD, which were coded and analyzed to identify themes. Grief was a nearly universal theme expressed among participants. Parents of younger children discussed grief in the context of receiving the diagnosis, whereas parents of older children indicated they were at different stages along the grieving journey when they received the diagnosis. Parents with less understanding of their child's prognosis (poorer prognostic awareness) connected their grief to receiving the diagnosis as this brought a clear understanding of the prognosis. Several themes suggested what providers did well to improve the diagnostic experience for parents, much of which aligns with existing literature around how to provide serious news. Additionally, parents identified long-term benefits of having a diagnosis for their child's medical problems. Although interview data were concordant with a survey of parents' diagnostic experience from a large international cohort, most participants in this study were relatively affluent, white mothers and further research is needed to better understand if other groups of parents have a different diagnostic experience. This study gives context of parental experience that providers should be aware of when conveying new genetic diagnoses to families. more...
- Published
- 2022
- Full Text
- View/download PDF
17. Contemporary Neuroscience Core Curriculum for Medical Schools.
- Author
-
Gelb DJ, Kraakevik J, Safdieh JE, Agarwal S, Odia Y, Govindarajan R, Quick A, Soni M, Bickel J, Gamaldo C, Hannon P, Hatch HAM, Hernandez C, Merlin LR, Noble JM, Reyes-Iglesias Y, Salas RME, Sandness DJ, Treat L, Benameur K, Brown RD Jr, DeLuca GC, Garg N, Goldstein LB, Gutmann L, Henchcliffe C, Hessler A, Jordan JT, Kilgore SM, Khan J, Levin KH, Mohile NA, Nevel KS, Roberts K, Said RR, Simpson EP, Sirven JI, Smith AG, Southerland AM, and Wilson RB more...
- Abstract
Medical students need to understand core neuroscience principles as a foundation for their required clinical experiences in neurology. In fact, they need a solid neuroscience foundation for their clinical experiences in all other medical disciplines also because the nervous system plays such a critical role in the function of every organ system. Because of the rapid pace of neuroscience discoveries, it is unrealistic to expect students to master the entire field. It is also unnecessary, as students can expect to have ready access to electronic reference sources no matter where they practice. In the preclerkship phase of medical school, the focus should be on providing students with the foundational knowledge to use those resources effectively and interpret them correctly. This article describes an organizational framework for teaching the essential neuroscience background needed by all physicians. This is particularly germane at a time when many medical schools are reassessing traditional practices and instituting curricular changes such as competency-based approaches, earlier clinical immersion, and increased emphasis on active learning. This article reviews factors that should be considered when developing the preclerkship neuroscience curriculum, including goals and objectives for the curriculum, the general topics to include, teaching and assessment methodology, who should direct the course, and the areas of expertise of faculty who might be enlisted as teachers or content experts. These guidelines were developed by a work group of experienced educators appointed by the Undergraduate Education Subcommittee (UES) of the American Academy of Neurology (AAN). They were then successively reviewed, edited, and approved by the entire UES, the AAN Education Committee, and the AAN Board of Directors., (© 2021 American Academy of Neurology.) more...
- Published
- 2021
- Full Text
- View/download PDF
18. Youth provide caregiving to adults with ALS: How do we support them?
- Author
-
Treat L
- Subjects
- Adaptation, Psychological, Adolescent, Adult, Child, Family, Humans, Amyotrophic Lateral Sclerosis, Caregivers
- Published
- 2020
- Full Text
- View/download PDF
19. Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.
- Author
-
Treat L, Chapman KE, Colborn KL, and Knupp KG
- Subjects
- Administration, Oral, Adolescent, Child, Child, Preschool, Cohort Studies, Epilepsy epidemiology, Female, Humans, Infant, Kaplan-Meier Estimate, Male, Plant Extracts therapeutic use, United States epidemiology, Anticonvulsants administration & dosage, Cannabidiol administration & dosage, Epilepsy drug therapy
- Abstract
Objective: Oral cannabis extracts (OCEs) are being used in the treatment of epilepsy with increasing rates in the United States following product legalization; however, no studies demonstrate clear efficacy. We evaluated the duration of use of OCEs as a measure of perceived benefit in a cohort of patients with pediatric epilepsy., Methods: Retrospective chart review was performed of children and adolescents who were given OCEs for treatment of epilepsy., Results: Of the 119 patients included in the analysis, 71% terminated use of their OCE product during the study period. The average length of use of OCE was 11.7 months (range 0.3-57 months). Perceived seizure benefit was the only factor associated with longer duration of treatment with OCE (p < 0.01). Relocation to Colorado was associated with perceived benefit of OCEs for seizures (65% vs. 38%, p = 0.01), but was not independently associated with longer OCE use. Factors associated with shorter use included adverse effects (p = 0.03) and a diagnosis of Dravet syndrome (p = 0.02). Twenty-four percent of patients were considered OCE responders, which was defined by a parent's report of a > 50% reduction in seizures while on this therapy. Adverse events (AEs) were reported in 19% of patients, with the most common side effects being somnolence and worsening of seizures., Significance: Parental report of OCE use in refractory pediatric epilepsy suggests that some families perceive benefit from this therapy; however, discontinuation of these products is common. Duration appears to be affected by logical factors, such as perceived benefit and side effect profile. Surprisingly, families of patients with Dravet syndrome terminated use of OCEs more quickly than patients with other epilepsy syndromes. Results from this study highlight the need for rigorous clinical studies to characterize the efficacy and safety of OCEs, which can inform discussions with patients and families., (Wiley Periodicals, Inc. © 2016 International League Against Epilepsy.) more...
- Published
- 2017
- Full Text
- View/download PDF
20. Patterns of complementary and alternative medicine use in children with common neurological conditions.
- Author
-
Treat L, Liesinger J, Ziegenfuss JY, Humeniuk K, Prasad K, and Tilburt JC
- Abstract
Background: Recent literature suggests that one in nine children in the United States uses some type of complementary and alternative medicine (CAM). Children with challenging neurological conditions such as headache, migraine, and seizures may seek CAM in their attempts at self-care. Our objective was to describe CAM use in children with these conditions., Methods: We compared use of CAM among children aged 3 to 17 years with and without common neurological conditions (headaches, migraines, seizures) where CAM might plausibly play a role in their self-management using the 2007 National Health Interview Survey (NHIS) data., Results: Children with common neurological conditions reported significantly more CAM use compared to the children without these conditions (24.0% vs 12.6%, P<.0001). Compared to other pediatric CAM users, children with neurological conditions report similarly high use of biological therapies and significantly higher use of mind-body techniques (38.6% vs 20.5%, P<.007). Of the mind-body techniques, deep breathing (32.5%), meditation (15.1%), and progressive relaxation (10.1%) were used most frequently., Conclusions: About one in four children with common neurological conditions use CAM. The nature of CAM use in this population, as well as its risks and benefits in neurological disease, deserve further investigation. more...
- Published
- 2014
- Full Text
- View/download PDF
21. A multi-center perspective of the Buttonhole Technique in the Pacific Northwest.
- Author
-
Ball LK, Treat L, Riffle V, Scherting D, and Swift L
- Subjects
- Anastomosis, Surgical standards, Catheterization, Humans, Northwestern United States, Total Quality Management, Anastomosis, Surgical methods
- Abstract
There is no solid data on how many dialysis facilities and home hemodialysis programs in the United States are cannulating arteriovenous fistulas via the Buttonhole Technique. In the Pacific Northwest (Northwest Renal Network #16), approximately 38% of facilities are utilizing the buttonhole technique. In this article, four of those facilities will share their experiences, which suggest the Buttonhole Technique is a viable AVF cannulation option that has fewer complications than site rotation and a higher level of patient satisfaction. more...
- Published
- 2007
22. A multidisciplinary team approach to increasing AV fistula creation.
- Author
-
Nguyen VD, Griffith C, and Treat L
- Subjects
- Aged, Comorbidity, Female, Humans, Kidney Failure, Chronic therapy, Male, Nephrology organization & administration, Referral and Consultation, Risk Factors, Washington, Arteriovenous Shunt, Surgical adverse effects, Arteriovenous Shunt, Surgical standards, Patient Care Team organization & administration, Renal Dialysis instrumentation, Total Quality Management organization & administration
- Abstract
Despite high patient comorbid factors, our Renal Care [table: see text] Group program was able to totally eliminate placement of AV grafts and to use only fistulae with an acceptable rate of catheter use--all within four years' time. This demonstrated the importance and value of a multidisciplinary vascular access team. Organization was the key element. All the team members were already in place prior to 1996, but they were not focused on vascular access and lacked education in this area. With the nephrologist not trained in fistula creation and not involved in that process, the absence of leadership led to a high number of dialysis grafts and catheters and frequent thrombotic and infectious complications. The nephrologist must assume the team leadership since he or she is the only provider who can interact with all other team members (see Table 3, p. 60). It is recommended that each nephrology group select a lead nephrologist to begin the team-building process (see Table 4, p. 60). A checklist (see Table 5) should be maintained for each pre-dialysis or dialysis patient as documentation for vein mapping and a surgical plan. This will make preoperative vein mapping mandatory for every patient. Education is important at all levels of the multidisciplinary team. This training effort should be started during nephrology fellowship, surgery and radiology residency, dialysis staff education programs, and renal networks. In 2002, the NW Renal Network led the way with fistula creation seminars, focusing on practicing nephrologists, surgeons, radiologists, and dialysis caregivers. The result of this Vascular Access Quality Improvement Program is pending. more...
- Published
- 2003
23. Early vegetative segregation of mitochondrial genes in Saccharomyces cerevisiae.
- Author
-
Treat LG and Birky CW Jr
- Subjects
- Alleles, Cell Division, Clone Cells, Diploidy, Genes, Models, Genetic, Regression Analysis, DNA, Mitochondrial genetics, Saccharomyces cerevisiae genetics
- Published
- 1980
- Full Text
- View/download PDF
24. Wire suturing technic for the repair of large wounds in horses.
- Author
-
Treat LA
- Subjects
- Animals, Horses, Methods, Wounds and Injuries surgery, Aluminum, Horse Diseases surgery, Suture Techniques veterinary, Wounds and Injuries veterinary
- Published
- 1969
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.